Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IRIX | US
-0.04
-3.86%
Healthcare
Medical Devices
30/06/2024
10/04/2026
1.00
1.03
1.03
1.00
IRIDEX Corporation an ophthalmic medical technology company provides therapeutic based laser systems delivery devices and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems which are used for the treatment of retinal disorders; and OcuLight TX OcuLight SL OcuLight SLx OcuLight GL and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy macular holes retinal tears and detachments. The company also provides delivery devices including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists research and teaching hospitals government installations surgical centers hospitals veterinary practices and office clinics. It markets its products through direct and independent sales force in the United States as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View California.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Asset (< 0.2)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
142.7%1 month
96.9%3 months
93.0%6 months
81.5%-
-
6.31
0.54
0.07
-3.61
0.50
-0.44
-9.93M
16.63M
16.63M
-
-20.89
-
-1.70
-122.71
16.66
1.89
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.27
Range1M
0.47
Range3M
0.70
Rel. volume
0.39
Price X volume
229.42K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| IceCure Medical Ltd. Ordinary Shares | ICCM | Medical Devices | 0.3233 | 16.01M | -4.91% | n/a | 4.90% |
| PetVivo Holdings Inc | PETV | Medical Devices | 0.7325 | 14.65M | 4.64% | n/a | 140.65% |
| TELA BIO INC | TELA | Medical Devices | 0.5674 | 14.02M | -4.73% | n/a | 1442.09% |
| Guided Therapeutics Inc | GTHP | Medical Devices | 0.2 | 13.97M | -16.60% | n/a | 0.00% |
| INBS | INBS | Medical Devices | 2.46 | 10.45M | -3.53% | n/a | 10.46% |
| Femasys Inc. Common Stock | FEMY | Medical Instruments & Supplies | 0.397 | 8.83M | 0.46% | n/a | 62.78% |
| Inspira Technologies OXY B.H.N. Ltd | IINN | Medical Devices | 0.4249 | 7.86M | 4.40% | n/a | 10.25% |
| Helius Medical Technologies Inc | HSDT | Medical Devices | 1.89 | 6.76M | 0.00% | n/a | 0.55% |
| Vivos Therapeutics Inc | VVOS | Medical Devices | 1.21 | 5.77M | 4.31% | n/a | 27.79% |
| Tivic Health Systems Inc. Common Stock | TIVC | Medical Devices | 0.9308 | 5.76M | -3.04% | 0.02 | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 11.76 | 17.91M | 6.72% | n/a | 204.46% |
| Fathom Holdings Inc | FTHM | Real Estate Services | 0.817 | 17.16M | -4.42% | n/a | 36.20% |
| AmBase Corporation | ABCP | Real Estate Services | 0.2 | 16.99M | -13.04% | n/a | 0.00% |
| FANGDD NETWORK GROUP LTD. | DUO | Real Estate Services | 1.2 | 16.19M | 2.56% | n/a | 0.70% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.08 | 15.78M | -6.90% | 0.03 | 16.03% |
| La Rosa Holdings Corp. Common Stock | LRHC | Real Estate Services | 0.425 | 7.57M | -22.97% | n/a | 76.18% |
| ALBT | ALBT | Real Estate Services | 0.457 | 7.30M | -7.25% | n/a | 187.39% |
| DigitalBridge Group Inc. | DBRG-PJ | Real Estate Services | 16.268 | 0 | 1.45% | n/a | 17.23% |
| DigitalBridge Group Inc. | DBRG-PI | Real Estate Services | 16.37 | 0 | 2.26% | n/a | 17.23% |
| DigitalBridge Group Inc. | DBRG-PH | Real Estate Services | 16.51 | 0 | 2.01% | n/a | 17.23% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.61 | 46.09 | Cheaper |
| Ent. to Revenue | 0.50 | 14.34 | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 6.31 | 6.21 | Par |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 93.00 | 64.12 | Riskier |
| Debt to Equity | 0.54 | -145.53 | Expensive |
| Debt to Assets | 0.07 | 0.35 | Cheaper |
| Market Cap | 16.63M | 9.70B | Emerging |